LNG Expansion And Biorefining Ventures Will Shape Future Energy Landscape

AN
AnalystConsensusTarget
Consensus Narrative from 22 Analysts
Published
07 Nov 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
€15.18
2.5% undervalued intrinsic discount
07 Aug
€14.80
Loading
1Y
2.4%
7D
0.9%

Author's Valuation

€15.2

2.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 3.90%

Shared on23 Apr 25
Fair value Decreased 5.07%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.79%

AnalystConsensusTarget has increased revenue growth from -0.9% to 1.6%.

Shared on09 Apr 25
Fair value Decreased 3.39%

AnalystConsensusTarget has decreased revenue growth from -0.7% to -0.9% and decreased discount rate from 13.3% to 11.8%.

Shared on02 Apr 25
Fair value Increased 5.53%

AnalystConsensusTarget has decreased revenue growth from -0.4% to -0.7% and decreased shares outstanding growth rate from -0.0% to -0.0%.

Shared on26 Mar 25
Fair value Decreased 4.47%

AnalystConsensusTarget has decreased revenue growth from 0.3% to -0.4%.

Shared on19 Mar 25
Fair value Increased 7.15%

AnalystConsensusTarget has increased revenue growth from 0.0% to 0.3%, increased future PE multiple from 9.9x to 12.2x, increased discount rate from 10.4% to 13.2% and increased shares outstanding growth rate from -0.0% to -0.0%.

Shared on12 Mar 25
Fair value Decreased 9.10%